Fig. 3

a Pooled analysis showing improved OS in overweight cancer patients compared with normal patients receiving immune checkpoint inhibitors treatment; b Pooled analysis showing improved OS in obese cancer patients compared with normal patients receiving immune checkpoint inhibitors treatment